SEC 13F Intelligence

Foresite Capital Management IV, LLC / XENE

Foresite Capital Management IV, LLC’s Xenon Pharmaceuticals Inc Position

Does Foresite Capital Management IV, LLC own Xenon Pharmaceuticals Inc (XENE)? Yes — 160.0K shares worth $9M (+3.92% of its 13F portfolio) as of Q1 2026.

Position Value
$9M
Q1 2026
Shares
160.0K
% of Portfolio
+3.92%
Quarters Held
4
currently held

Position History XENE

Reported value by quarter
Q2 ’25: $5MQ2 ’25Q3 ’25: $6MQ3 ’25Q4 ’25: $7MQ4 ’25Q1 ’26: $9MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026160.0K$9M+3.92%
Q4 2025160.0K$7M+3.12%
Q3 2025160.0K$6M+3.52%
Q2 2025160.0K$5M+4.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of XENE.